Advertisement

Whole egg consumption improves lipoprotein profiles and insulin sensitivity to a greater extent than yolk-free egg substitute in individuals with metabolic syndrome

Published:September 28, 2012DOI:https://doi.org/10.1016/j.metabol.2012.08.014

      Abstract

      Objective

      We investigated if daily egg feeding, along with carbohydrate restriction, would alter lipoprotein metabolism and influence atherogenic lipoprotein profiles and insulin resistance in men and women with metabolic syndrome (MetS).

      Methods

      In a randomized, single-blind, parallel design, participants consumed either 3 whole eggs/day (EGG, n=20) or the equivalent amount of yolk-free egg substitute (SUB, n=17), as part of a moderately carbohydrate-restricted diet (25%–30% energy) for 12 weeks. Plasma lipids, apolipoproteins (apos), oxidized LDL (oxLDL), cholesteryl ester transfer protein (CETP) and lecithin-cholesterol acyltransferase (LCAT) activities were assessed at baseline and week 12. Lipoprotein particle concentrations and sizes were measured by nuclear magnetic resonance spectroscopy.

      Results

      Atherogenic dyslipidemia improved for all individuals as evidenced by reductions in plasma triglycerides, apoC-III, apoE, oxLDL, VLDL particle diameter, large VDL, total IDL, small LDL, and medium LDL particles (P<0.05). Furthermore, there were increases in HDL-cholesterol, large LDL and large HDL particles (P<0.05) for all individuals. However, there were greater increases in HDL-cholesterol and large HDL particles, and reductions in total VLDL and medium VLDL particles for those consuming EGG compared to SUB (P<0.05). Plasma insulin and insulin resistance (HOMA-IR) were reduced, while LCAT activity, and both HDL and LDL diameters increased over time in the EGG group only (P<0.05).

      Conclusions

      Incorporating daily whole egg intake into a moderately carbohydrate-restricted diet provides further improvements in the atherogenic lipoprotein profile and in insulin resistance in individuals with MetS.

      Abbreviations:

      Apo (apolipoprotein), CETP (cholesteryl ester transfer protein), CHD (coronary heart disease), CRD (carbohydrate-restricted diet), CVD (cardiovascular disease), EGG (3 whole eggs per day), HDL-C (HDL-cholesterol), LCAT (lecithin-cholesterol acyltransferase), LDL-C (LDL-cholesterol), LPL (lipoprotein lipase), MetS (metabolic syndrome), NCEP: ATP III (National Cholesterol Education Program Adult Treatment Panel III), NMR (nuclear magnetic resonance), oxLDL (oxidized LDL), SUB (egg substitute), TC (total cholesterol), TG (triglycerides)

      Keywords

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'

      Subscribe:

      Subscribe to Metabolism - Clinical and Experimental
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect

      References

        • Grundy S.M.
        • Brewer Jr., H.B.
        • Cleeman J.I.
        • et al.
        Definition of metabolic syndrome: report of the National Heart, Lung, and Blood Institute/American Heart Association conference on scientific issues related to definition.
        Arterioscler Thromb Vasc Biol. 2004; 24: e13-e18
        • Berneis K.K.
        • Krauss R.M.
        Metabolic origins and clinical significance of LDL heterogeneity.
        J Lipid Res. 2002; 43: 1363-1379
        • Holvoet P.
        • Kritchevsky S.B.
        • Tracy R.P.
        • et al.
        The metabolic syndrome, circulating oxidized LDL, and risk of myocardial infarction in well-functioning elderly people in the health, aging, and body composition cohort.
        Diabetes. 2004; 53: 1068-1073
        • Kathiresan S.
        • Otvos J.D.
        • Sullivan L.M.
        • et al.
        Increased small low-density lipoprotein particle number: a prominent feature of the metabolic syndrome in the Framingham Heart Study.
        Circulation. 2006; 113: 20-29
        • Kontush A.
        • Chapman M.J.
        Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis.
        Pharmacol Rev. 2006; 58: 342-374
        • Mora S.
        • Otvos J.D.
        • Rifai N.
        • et al.
        Lipoprotein particle profiles by nuclear magnetic resonance compared with standard lipids and apolipoproteins in predicting incident cardiovascular disease in women.
        Circulation. 2009; 119: 931-939
        • El Harchaoui K.
        • Arsenault B.J.
        • Franssen R.
        • et al.
        High-density lipoprotein particle size and concentration and coronary risk.
        Ann Intern Med. 2009; 150: 84-93
        • Adiels M.
        • Olofsson S.O.
        • Taskinen M.R.
        • et al.
        Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome.
        Arterioscler Thromb Vasc Biol. 2008; 28: 1225-1236
      1. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III).
        JAMA. 2001; 285: 2486-2497
        • Volek J.S.
        • Fernandez M.L.
        • Feinman R.D.
        • et al.
        Dietary carbohydrate restriction induces a unique metabolic state positively affecting atherogenic dyslipidemia, fatty acid partitioning, and metabolic syndrome.
        Prog Lipid Res. 2008; 47: 307-318
        • Petersen K.F.
        • Dufour S.
        • Savage D.B.
        • et al.
        The role of skeletal muscle insulin resistance in the pathogenesis of the metabolic syndrome.
        Proc Natl Acad Sci U S A. 2007; 104: 12587-12594
        • Fernandez M.L.
        Dietary cholesterol provided by eggs and plasma lipoproteins in healthy populations.
        Curr Opin Clin Nutr Metab Care. 2006; 9: 8-12
        • Mutungi G.
        • Waters D.
        • Ratliff J.
        • et al.
        Eggs distinctly modulate plasma carotenoid and lipoprotein subclasses in adult men following a carbohydrate-restricted diet.
        J Nutr Biochem. 2010; 21: 261-267
        • Herron K.L.
        • Lofgren I.E.
        • Sharman M.
        • et al.
        High intake of cholesterol results in less atherogenic low-density lipoprotein particles in men and women independent of response classification.
        Metabolism. 2004; 53: 823-830
        • Djousse L.
        • Gaziano J.M.
        Egg consumption in relation to cardiovascular disease and mortality: the Physicians' Health Study.
        Am J Clin Nutr. 2008; 87: 964-969
        • Friedewald W.T.
        • Levy R.I.
        • Fredrickson D.S.
        Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge.
        Clin Chem. 1972; 18: 499-502
        • Matthews D.R.
        • Hosker J.P.
        • Rudenski A.S.
        • et al.
        Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
        Diabetologia. 1985; 28: 412-419
        • Freedman D.S.
        • Otvos J.D.
        • Jeyarajah E.J.
        • et al.
        Relation of lipoprotein subclasses as measured by proton nuclear magnetic resonance spectroscopy to coronary artery disease.
        Arteriosclerosis, thrombosis, and vascular biology. 1998; 18: 1046-1053
        • Davidson M.H.
        • Ballantyne C.M.
        • Jacobson T.A.
        • et al.
        Clinical utility of inflammatory markers and advanced lipoprotein testing: advice from an expert panel of lipid specialists.
        J Clin Lipidol. 2011; 5: 338-367
        • Arsenault B.J.
        • Lemieux I.
        • Despres J.P.
        • et al.
        Comparison between gradient gel electrophoresis and nuclear magnetic resonance spectroscopy in estimating coronary heart disease risk associated with LDL and HDL particle size.
        Clin Chem. 2010; 56: 789-798
        • Otvos J.D.
        • Collins D.
        • Freedman D.S.
        • et al.
        Low-density lipoprotein and high-density lipoprotein particle subclasses predict coronary events and are favorably changed by gemfibrozil therapy in the Veterans Affairs High-Density Lipoprotein Intervention Trial.
        Circulation. 2006; 113: 1556-1563
        • Festa A.
        • Williams K.
        • Hanley A.J.
        • et al.
        Nuclear magnetic resonance lipoprotein abnormalities in prediabetic subjects in the Insulin Resistance Atherosclerosis Study.
        Circulation. 2005; 111: 3465-3472
        • Hodge A.M.
        • Jenkins A.J.
        • English D.R.
        • et al.
        NMR-determined lipoprotein subclass profile predicts type 2 diabetes.
        Diabetes Res Clin Pract. 2009; 83: 132-139
        • Rensen P.C.
        • van Berkel T.J.
        Apolipoprotein E effectively inhibits lipoprotein lipase-mediated lipolysis of chylomicron-like triglyceride-rich lipid emulsions in vitro and in vivo.
        J Biol Chem. 1996; 271: 14791-14799
        • Tomiyasu K.
        • Walsh B.W.
        • Ikewaki K.
        • et al.
        Differential metabolism of human VLDL according to content of ApoE and ApoC-III.
        Arterioscler Thromb Vasc Biol. 2001; 21: 1494-1500
        • Ballesteros M.N.
        • Cabrera R.M.
        • Cabrera R.M.
        • Saucedo Mdel S.
        • et al.
        Dietary cholesterol does not increase biomarkers for chronic disease in a pediatric population from northern Mexico.
        Am J Clin Nutr. 2004; 80: 855-861
        • Gasevic D.
        • Frohlich J.
        • Mancini G.B.
        • et al.
        The association between triglyceride to high-density-lipoprotein cholesterol ratio and insulin resistance in a multiethnic primary prevention cohort.
        Metabolism. 2012; 61: 583-589
        • Sniderman A.
        • Vu H.
        • Cianflone K.
        Effect of moderate hypertriglyceridemia on the relation of plasma total and LDL apo B levels.
        Atherosclerosis. 1991; 89: 109-116
        • Asztalos B.F.
        • Tani M.
        • Schaefer E.J.
        Metabolic and functional relevance of HDL subspecies.
        Curr Opin Lipidol. 2011; 22: 176-185
        • Asztalos B.F.
        • Batista M.
        • Horvath K.V.
        • et al.
        Change in alpha1 HDL concentration predicts progression in coronary artery stenosis.
        Arterioscler Thromb Vasc Biol. 2003; 23: 847-852
        • Jones J.L.
        • Comperatore M.
        • Barona J.
        • et al.
        A Mediterranean-style, low-glycemic-load diet decreases atherogenic lipoproteins and reduces lipoprotein (a) and oxidized low-density lipoprotein in women with metabolic syndrome.
        Metabolism. 2012; 61: 366-372
        • Al-Sarraj T.
        • Saadi H.
        • Volek J.S.
        • et al.
        Carbohydrate restriction favorably alters lipoprotein metabolism in Emirati subjects classified with the metabolic syndrome.
        Nutr Metab Cardiovasc Dis. 2010; 20: 720-726
        • Kuller L.H.
        • Grandits G.
        • Cohen J.D.
        • et al.
        Lipoprotein particles, insulin, adiponectin, C-reactive protein and risk of coronary heart disease among men with metabolic syndrome.
        Atherosclerosis. 2007; 195: 122-128
        • Cheung M.C.
        • Albers J.J.
        Distribution of high density lipoprotein particles with different apoprotein composition: particles with A-I and A-II and particles with A-I but no A-II.
        J Lipid Res. 1982; 23: 747-753
        • Chan D.C.
        • Ng T.W.
        • Watts G.F.
        Apolipoprotein A-II: evaluating its significance in dyslipidaemia, insulin resistance, and atherosclerosis.
        Ann Med. 2012; 44: 313-324
        • Rothblat G.H.
        • Phillips M.C.
        High-density lipoprotein heterogeneity and function in reverse cholesterol transport.
        Curr Opin Lipidol. 2010; 21: 229-238
        • Rousset X.
        • Shamburek R.
        • Vaisman B.
        • et al.
        Lecithin cholesterol acyltransferase: an anti- or pro-atherogenic factor?.
        Curr Atheroscler Rep. 2011; 13: 249-256
        • Dow C.A.
        • Going S.B.
        • Chow H.H.
        • et al.
        The effects of daily consumption of grapefruit on body weight, lipids, and blood pressure in healthy, overweight adults.
        Metabolism. 2012; 61: 1026-1035
        • Li S.C.
        • Liu Y.H.
        • Liu J.F.
        • et al.
        Almond consumption improved glycemic control and lipid profiles in patients with type 2 diabetes mellitus.
        Metabolism. 2011; 60: 474-479
        • Kovacs-Nolan J.
        • Phillips M.
        • Mine Y.
        Advances in the value of eggs and egg components for human health.
        J Agric Food Chem. 2005; 53: 8421-8431
        • O'Brien B.C.
        • Corrigan S.M.
        Influence of dietary soybean and egg lecithins on lipid responses in cholesterol-fed guinea pigs.
        Lipids. 1988; 23: 647-650
        • Burgess J.W.
        • Neville T.A.
        • Rouillard P.
        • et al.
        Phosphatidylinositol increases HDL-C levels in humans.
        J Lipid Res. 2005; 46: 350-355